Correlation Between Pfizer and Growth For
Can any of the company-specific risk be diversified away by investing in both Pfizer and Growth For at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Growth For into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Growth For Good, you can compare the effects of market volatilities on Pfizer and Growth For and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Growth For. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Growth For.
Diversification Opportunities for Pfizer and Growth For
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Growth is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Growth For Good in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Growth For Good and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Growth For. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Growth For Good has no effect on the direction of Pfizer i.e., Pfizer and Growth For go up and down completely randomly.
Pair Corralation between Pfizer and Growth For
If you would invest 1,047 in Growth For Good on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Growth For Good or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 0.4% |
Values | Daily Returns |
Pfizer Inc vs. Growth For Good
Performance |
Timeline |
Pfizer Inc |
Growth For Good |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Growth For Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Growth For
The main advantage of trading using opposite Pfizer and Growth For positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Growth For can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Growth For will offset losses from the drop in Growth For's long position.Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
Growth For vs. Finnovate Acquisition Corp | Growth For vs. Broad Capital Acquisition | Growth For vs. Welsbach Technology Metals | Growth For vs. Gores Holdings IX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |